Summary: The global biosimilar market size reached USD 21.2 billion in 2023. The market is expected to reach USD 164.5 Billion by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032. Europe leads the market, accounting for the largest biosimilar market share. Infliximab accounts for the majority of the market share in the molecule segment due to it's frequently used to treat...